SCHEMBL24627544

SCHEMBL24627544

CCCCC/C=C\C/C=C\CCCCCCCCOC(=O)CCN(CCCCN(C)C)CCC(=O)OCCCCCCCC/C=C\C/C=C\CCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.55
ALDH1A1 P00352 5/20 0.54
MAPT P10636 1/20 0.54
THRB P10828 1/20 0.54
CNR1 P21554 1/20 0.54
DNM1 Q05193 1/20 0.51
FAAH O00519 1/20 0.51
F7 P08709 3/20 0.46
F3 P13726 3/20 0.46
KDM4E B2RXH2 2/20 0.46
PPARG P37231 2/20 0.46
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
DUSP3 P51452 1/20 0.46
PTPN7 P35236 1/20 0.46
FFAR1 O14842 1/20 0.46
LMNA P02545 1/20 0.46
FABP3 P05413 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP19A1 P11511 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627656 1.00 MGLL (0.55) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL24627584 1.00 MGLL (0.55) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL24627505 0.98 MGLL (0.55) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL24627685 0.95 MGLL (0.59) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL24627568 0.94 MGLL (0.56) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL25801068 0.94 DNM1 (0.55) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL25076629 0.93 MGLL (0.56) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL24627812 0.93 MGLL (0.56) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL25076710 0.93 MGLL (0.55) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL24627526 0.92 MGLL (0.57) MGLLALDH1A1MAPTTHRBCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF NPC1L1, PLA2G4A, PLA2G2A MGLL 429/4885ALDH1A1 3237/4885MAPT 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.